187 related articles for article (PubMed ID: 8689603)
21. Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC.
Sozzi G; Pierotti MA; Miozzo M; Donghi R; Radice P; De Benedetti V; Grieco M; Santoro M; Fusco A; Vecchio G
Oncogene; 1991 Feb; 6(2):339-42. PubMed ID: 2000227
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
[TBL] [Abstract][Full Text] [Related]
23. RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Viglietto G; Chiappetta G; Martinez-Tello FJ; Fukunaga FH; Tallini G; Rigopoulou D; Visconti R; Mastro A; Santoro M; Fusco A
Oncogene; 1995 Sep; 11(6):1207-10. PubMed ID: 7566982
[TBL] [Abstract][Full Text] [Related]
24. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
25. The ret/PTC oncogene in papillary thyroid carcinoma.
Jhiang SM; Mazzaferri EL
J Lab Clin Med; 1994 Mar; 123(3):331-7. PubMed ID: 8133143
[No Abstract] [Full Text] [Related]
26. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation.
Cetta F; Gori M; Montalto G; Zuckermann M; Toti P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550
[No Abstract] [Full Text] [Related]
27. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
[TBL] [Abstract][Full Text] [Related]
29. In vitro irradiation is able to cause RET oncogene rearrangement.
Ito T; Seyama T; Iwamoto KS; Hayashi T; Mizuno T; Tsuyama N; Dohi K; Nakamura N; Akiyama M
Cancer Res; 1993 Jul; 53(13):2940-3. PubMed ID: 8319199
[TBL] [Abstract][Full Text] [Related]
30. RET oncogene activation in papillary thyroid carcinoma.
Tallini G; Asa SL
Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
[TBL] [Abstract][Full Text] [Related]
31. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
32. Thyroid carcinomas in RET/PTC transgenic mice.
Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
[TBL] [Abstract][Full Text] [Related]
33. H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.
Celetti A; Cerrato A; Merolla F; Vitagliano D; Vecchio G; Grieco M
Oncogene; 2004 Jan; 23(1):109-21. PubMed ID: 14712216
[TBL] [Abstract][Full Text] [Related]
34. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
[TBL] [Abstract][Full Text] [Related]
35. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Mayr B; Brabant G; Goretzki P; Rüschoff J; Dietmaier W; Dralle H
J Clin Endocrinol Metab; 1997 Apr; 82(4):1306-7. PubMed ID: 9100614
[No Abstract] [Full Text] [Related]
36. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
37. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M
Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893
[TBL] [Abstract][Full Text] [Related]
38. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
39. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
[TBL] [Abstract][Full Text] [Related]
40. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]